Candida parapsilosis

Candida parapsilosis
Scientific classification Edit this classification
Kingdom: Fungi
Division: Ascomycota
Class: Saccharomycetes
Order: Saccharomycetales
Family: Debaryomycetaceae
Genus: Candida
Species:
C. parapsilosis
Binomial name
Candida parapsilosis
Langeron & Talice (1932)
Synonyms

Candida parapsilosis is a fungal species of yeast that has become a cause of sepsis and of wound and tissue infections in people who have immune system defects. Unlike Candida albicans and Candida tropicalis, C. parapsilosis is not an obligate human pathogen. C. parapsilosis normally lives on humans as a commensal yeast. It is one of the fungi most frequently isolated from human hands. There are several risk factors that can contribute to C. parapsilosis infection. Those with immune system diseases have a high risk of having a C. parapsilosis infection. These include surgical patients. There is currently no agreement on the treatment of invasive candidiasis caused by C. parapsilosis. The approach includes the removal of foreign bodies such as implanted prostheses. Medication is given to treat the infection. The use of antifungal therapy includes amphotericin B and fluconazole.

History and taxonomy

Candida parapsilosis was discovered in Puerto Rico in 1928. Ashford collected it from a diarrheal stool. It was first named Monilia parapsilosis and was considered to not be the cause of infection. It was found to be a causative agent of sepsis in an intravenous drug user in 1940. It is now considered an important hospital disease caused by fungi. C. parapsilosis is the most common non-C. albicans species of Candida. It is the second most common pathogen in superficial candidiasis after C. albicans.

Biology

C. parapsilosis is white, creamy, and shiny when grown on dextrose agar. Its cell shape is oval, round, or like a cylinder. When C. parapsilosis is found more often in nature than other species Candida. This is likely because it is one of the few species of the genus not restricted to humans. Invasive infection occurs often in low-birth weight newborn babies in the United States. And it is a bloodstream infection found in North America. It is most commonly found on human skin and is most frequently encountered in Asia and Latin America. It can make chemicals that will destroy the cells of other organisms.

Disease

Endocarditis can be caused by C. parapsilosis in patients using

The mortality rate is 41.7% to 61%. Ocular infection caused by C. parapsilosis has been found after cataract removal and with corticosteroid eye drop use. C. parapsilosis infection of the skin and gastrointestinal tract can occur.in which the production of pseudohyphae is associated with the elicitation of an inflammatory response. Candida parapsilosis is occasionally encountered in toenail fungus.

Serious C. parapilosis infection is mostly due to the use of in-dwelling devices. It can stick to other organisms' cells. It can also adhere to tissue, especially mucosal surfaces. C. parapsilosis can be found with thin, unstructured biofilms. The existence of the fungus in a biofilm helps it resist antifungal treatment. Thus, adhesion to abiotic and biotic surfaces is often a precursor to serious infection. The risk of C. parapsilosis infection is increased in the setting of implanted medical devices, prostheses, and therapy with feeding solutions. Also, low-birth weight infants are at higher risk of sepsis from this species.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 David Trofa; Attila Gácser; Joshua D. Nosanchuk (2008). "Candida parapsilosis, an Emerging Fungal Pathogen". Clin Microbiol Rev. 21 (4): 606–025. doi:10.1128/CMR.00013-08. PMC 2570155. PMID 18854483.
  2. 1 2 M. de Toro; M. J. Torres; Ruiz Maite; J. Aznar (2010). "Characterization of Candida parapsilosis complex isolates". Clinical Microbiology and Infection. 17 (3): 418–424. doi:10.1111/j.1469-0691.2010.03302.x. PMID 20636431.
  3. 1 2 Adél Tóth; Erik Zajta; Katalin Csonka; Csaba Vágvölgyi; Mihai G. Netea; Attila Gácser (2017). "Specific pathways mediating inflammasome activation by Candida parapsilosis". Scientific Reports. 7 43129. Bibcode:2017NatSR...743129T. doi:10.1038/srep43129. PMC 5320503. PMID 28225025.
  4. 1 2 Xiaobo Feng; Bo Ling; Guimei Yang; Xia Yu; Daming Ren; Zhirong Yao (2012). "Prevalence and Distribution Profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis Responsible for Superficial Candidiasis in a Chinese University Hospital". Mycopathologia. 173 (4): 229–234. doi:10.1007/s11046-011-9496-5. PMID 22102007. S2CID 18867907.
  5. ↑ Efrén Robledo-Leal; Mariana Elizondo-Zertuche; Licet Villarreal-Treviño; Rogelio de J. Treviño-Rangel; Nancy García-Maldonado; Juan M. Adame-Rodríguez; Gloria M. González (2014). "Killer behavior within the Candida parapsilosis complex". Folia Microbiologica. 59 (6): 503–506. doi:10.1007/s12223-014-0327-1. PMID 24898174. S2CID 884540.
  6. ↑ Segal R, Kritzman A, Cividalli L, Samra Z, David M, Tiqva P (1996). "Treatment of Candida nail infection with terbinafine". Journal of the American Academy of Dermatology. 35 (6): 958–961. doi:10.1016/s0190-9622(96)90120-6. PMID 8959955.
  7. ↑ Supram Hosuru Subramanya; Deependra Hamal; Niranjan Nayak; Shishir Gokhale (2016). "Onychomycosis due to Candida parapsilosis in a Child with Ventricular Septal Defect: An Unusual Predisposition". Case Reports in Pediatrics. 2016: 1–4. doi:10.1155/2016/7026068. PMC 4852352. PMID 27195165.
  8. ↑ Different toenail onychomycosis due to Rhodotorula mucilaginosa and Candida parapsilosis in an immunocompetent young adult, Gai Ge, a Dongmei Li, b Huan Mei, c Guixia Lu, c Hailin Zheng, c Weida Liu, c and Dongmei Shid,∗
  9. 1 2 Duncan M. Kuhn; Pranab K. Mukherjee; Thomas A. Clark; Claude Pujol; Jyotsna Chandra; Rana A. Hajjeh; David W. Warnock; David R. Soll; Mahmoud A. Ghannoum (2004). "Candida parapsilosis Characterization in an Outbreak Setting". Emerging Infectious Diseases. 10 (6): 1074–1081. doi:10.3201/eid1006.030873. PMC 3323144. PMID 15207060.
  10. ↑ Sonia Silva; Melyssa Negri; Mariana Henriques; Rosario Oliveira; David W. Williams; Joana Azeredo (2012). "Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicityand antifungal resistance". FEMS Microbiology Letters. 36 (2): 288–305. doi:10.1111/j.1574-6976.2011.00278.x. PMID 21569057.
  11. ↑ Alessia Bertini; Flavia De Bernardis; Lambert A.M. Hensgens; Silvia Sandini; Sonia Senesi; Arianna Tavanti (2013). "Comparison of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis adhesive properties and pathogenicity". International Journal of Medical Microbiology. 303 (2): 98–103. doi:10.1016/j.ijmm.2012.12.006. PMID 23403338.
  12. ↑ Itzhak Levy; Lorry G. Rubin; Sanjeev Vasishtha; Victor Tucci; Sunil K. Sood (1998). "Emergence of Candida parapsilosis as the Predominant Species Causing Candidemia in Children". Clinical Infectious Diseases. 26 (5): 1086–1088. doi:10.1086/520277. PMID 9597232.